Windlas Biotech shares have gained nearly 9% in the last three months. SEBI-registered analyst Finkhoz is bullish on the stock, driven by its improving fundamental strength and a bullish chart setup.
Windlas Biotech Ltd (Windlas) has quietly positioned itself as one of the more interesting mid-cap plays on India’s pharmaceuticals outsourcing wave. The company, headquartered in Dehradun, is ...
WINDLAS BIOTECH LTD - Board Meeting Intimation for Approval Of The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended September 30, 2025. - Rediff MoneyWiz, ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results